JP2018513868A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018513868A5 JP2018513868A5 JP2017555374A JP2017555374A JP2018513868A5 JP 2018513868 A5 JP2018513868 A5 JP 2018513868A5 JP 2017555374 A JP2017555374 A JP 2017555374A JP 2017555374 A JP2017555374 A JP 2017555374A JP 2018513868 A5 JP2018513868 A5 JP 2018513868A5
- Authority
- JP
- Japan
- Prior art keywords
- agents
- virus
- compound
- drugs
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 Cc1c(*)cn[o]1 Chemical compound Cc1c(*)cn[o]1 0.000 description 4
- ADGOPPKEIZXKAZ-UHFFFAOYSA-N Cc1c(-c2cc(-c3ccnc(Nc4cc(NC(c5ccc(CN6CCN(C)CC6)cc5)=O)ccc4C)n3)cnc2)[o]nc1 Chemical compound Cc1c(-c2cc(-c3ccnc(Nc4cc(NC(c5ccc(CN6CCN(C)CC6)cc5)=O)ccc4C)n3)cnc2)[o]nc1 ADGOPPKEIZXKAZ-UHFFFAOYSA-N 0.000 description 1
- OWBTYLSRODUZAK-UHFFFAOYSA-N Cc1c(C(N)=O)[nH]nc1 Chemical compound Cc1c(C(N)=O)[nH]nc1 OWBTYLSRODUZAK-UHFFFAOYSA-N 0.000 description 1
- VQTVFIMEENGCJA-UHFFFAOYSA-N Cc1c(C)[nH]nc1 Chemical compound Cc1c(C)[nH]nc1 VQTVFIMEENGCJA-UHFFFAOYSA-N 0.000 description 1
- BSWGZCMLNFBDEZ-UHFFFAOYSA-N Cc1c(C)[o]nc1 Chemical compound Cc1c(C)[o]nc1 BSWGZCMLNFBDEZ-UHFFFAOYSA-N 0.000 description 1
- PSOZJOZKEVZLKZ-UHFFFAOYSA-N Cc1c[o]c(C)n1 Chemical compound Cc1c[o]c(C)n1 PSOZJOZKEVZLKZ-UHFFFAOYSA-N 0.000 description 1
- KBOSIRPMGVGOEP-UHFFFAOYSA-N Cc1cc(C(N)=O)n[o]1 Chemical compound Cc1cc(C(N)=O)n[o]1 KBOSIRPMGVGOEP-UHFFFAOYSA-N 0.000 description 1
- FICAQKBMCKEFDI-UHFFFAOYSA-N Cc1n[o]c(C)c1 Chemical compound Cc1n[o]c(C)c1 FICAQKBMCKEFDI-UHFFFAOYSA-N 0.000 description 1
- OBFUZQPNGSXDLY-UHFFFAOYSA-N Cc1nc(C(N)=O)c[o]1 Chemical compound Cc1nc(C(N)=O)c[o]1 OBFUZQPNGSXDLY-UHFFFAOYSA-N 0.000 description 1
- XEFYPTQOROORRU-UHFFFAOYSA-N Cc1ncc(C(N)=O)[o]1 Chemical compound Cc1ncc(C(N)=O)[o]1 XEFYPTQOROORRU-UHFFFAOYSA-N 0.000 description 1
- YVDWFZIVIIKYBQ-UHFFFAOYSA-N Cc1nnc(C)[o]1 Chemical compound Cc1nnc(C)[o]1 YVDWFZIVIIKYBQ-UHFFFAOYSA-N 0.000 description 1
- ZMSIFDIKIXVLDF-UHFFFAOYSA-N Cc1nnc[o]1 Chemical compound Cc1nnc[o]1 ZMSIFDIKIXVLDF-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562151659P | 2015-04-23 | 2015-04-23 | |
| US62/151,659 | 2015-04-23 | ||
| US201562182955P | 2015-06-22 | 2015-06-22 | |
| US62/182,955 | 2015-06-22 | ||
| PCT/US2016/028914 WO2016172528A1 (en) | 2015-04-23 | 2016-04-22 | Compositions and methods for inhibiting kinases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018513868A JP2018513868A (ja) | 2018-05-31 |
| JP2018513868A5 true JP2018513868A5 (https=) | 2019-05-23 |
| JP6795518B2 JP6795518B2 (ja) | 2020-12-02 |
Family
ID=57144281
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555374A Active JP6795518B2 (ja) | 2015-04-23 | 2016-04-22 | キナーゼを阻害する組成物及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (8) | US9828370B2 (https=) |
| EP (1) | EP3286179A4 (https=) |
| JP (1) | JP6795518B2 (https=) |
| AU (2) | AU2016252860B2 (https=) |
| CA (1) | CA2980478C (https=) |
| WO (1) | WO2016172528A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3286179A4 (en) * | 2015-04-23 | 2018-08-29 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
| US20200046699A1 (en) * | 2016-10-25 | 2020-02-13 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
| US10855891B2 (en) | 2016-11-21 | 2020-12-01 | Samsung Electro-Mechanics Co., Ltd. | Apparatus for controlling position of camera module |
| US20220010382A1 (en) * | 2018-11-12 | 2022-01-13 | Blueprint Medicines Corporation | Avapritinib resistance of kit mutants |
| CN114127065A (zh) * | 2019-03-05 | 2022-03-01 | 鸿仪有限责任公司 | 用于治疗神经退行性疾病和癌症的化合物 |
| CN115175673A (zh) * | 2020-02-26 | 2022-10-11 | 上海科技大学 | 双硫仑在抗冠状病毒中的应用 |
| CA3176661A1 (en) * | 2020-04-24 | 2021-10-28 | Memorial Sloan-Kettering Cancer Center | Targeted therapy for the treatment & prevention of life-threatening complications of infection |
| CN112552283A (zh) * | 2020-12-07 | 2021-03-26 | 天津羲泽润科技有限公司 | 一种新型替尼类药物的制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE454152T1 (de) * | 2003-06-13 | 2010-01-15 | Novartis Pharma Gmbh | 2-aminopyrimidin-derivate als raf-kinase-hemmer |
| US8268809B2 (en) * | 2006-09-05 | 2012-09-18 | Emory University | Kinase inhibitors for preventing or treating pathogen infection and method of use thereof |
| US8466154B2 (en) * | 2006-10-27 | 2013-06-18 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to wrapping of dehydrons |
| CN102406648A (zh) | 2010-09-21 | 2012-04-11 | 中国科学院生物物理研究所 | 甲磺酸伊马替尼在制备抗帕金森病药物中的应用 |
| WO2013171642A1 (en) | 2012-05-15 | 2013-11-21 | Novartis Ag | Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1 |
| AU2013326850B2 (en) | 2012-10-04 | 2017-09-21 | Inhibikase Therapeutics, Inc. | Novel compounds, their preparation and their uses |
| EP3286179A4 (en) | 2015-04-23 | 2018-08-29 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
| US20200046699A1 (en) | 2016-10-25 | 2020-02-13 | Inhibikase Therapeutics, Inc. | Compositions and methods for inhibiting kinases |
-
2016
- 2016-04-22 EP EP16783966.1A patent/EP3286179A4/en active Pending
- 2016-04-22 US US15/136,497 patent/US9828370B2/en active Active
- 2016-04-22 CA CA2980478A patent/CA2980478C/en active Active
- 2016-04-22 JP JP2017555374A patent/JP6795518B2/ja active Active
- 2016-04-22 AU AU2016252860A patent/AU2016252860B2/en active Active
- 2016-04-22 WO PCT/US2016/028914 patent/WO2016172528A1/en not_active Ceased
-
2017
- 2017-11-07 US US15/805,693 patent/US10118923B2/en active Active
-
2018
- 2018-10-24 US US16/169,677 patent/US10316031B2/en active Active
- 2018-10-24 US US16/169,683 patent/US10344027B2/en active Active
-
2019
- 2019-06-26 US US16/452,828 patent/US10906896B2/en active Active
-
2020
- 2020-12-14 AU AU2020286339A patent/AU2020286339B2/en active Active
-
2021
- 2021-01-05 US US17/141,825 patent/US11407747B2/en active Active
-
2022
- 2022-06-24 US US17/849,141 patent/US11725005B2/en active Active
-
2024
- 2024-09-24 US US18/894,338 patent/US20250250266A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018513868A5 (https=) | ||
| US9271984B2 (en) | Treatment of type 1 diabetes | |
| FI3908270T3 (fi) | Faanin ja bupropionin yhdistelmä masennuksen hoitoon aasialaisilla potilailla | |
| RU2017114352A (ru) | АНТАГОНИСТЫ ИНТЕГРИНА ανβ6 | |
| JP2018510178A5 (https=) | ||
| AU2015205188A1 (en) | Pharmaceutical preparation containing pyridylamino acetic acid compound | |
| CZ20033115A3 (cs) | Léčivo pro léčení a/nebo profylaxi stavů charakterizovaných změněnou funkcí střev a/nebo viscerální bolestí | |
| FI4210700T3 (fi) | Somatostatiinimodulaatorin formulaatioita | |
| RU2004109920A (ru) | Фармацевтическая композиция, включающая лумиракоксиб | |
| JP2009525265A5 (https=) | ||
| RU2017127509A (ru) | Композиции и способы для улучшенного мышечного метаболизма | |
| DE69412662T2 (de) | Angiotensin II-Antagonisten zur Behandlung von viralen Erkrankungen | |
| RU2005129333A (ru) | 4-[(2,4-дихлор-5-метоксифенил)амино]-6-алкокси-3-хинолинкарбонитрилы для лечения ишемического повреждения | |
| CA2403994A1 (en) | Nasal administration of agents for the treatment of gastroparesis | |
| KR102879944B1 (ko) | Hiv 예방용 인테그라제 억제제 | |
| US10537574B2 (en) | Use of kinase inhibitors to manage tuberculosis and other infectious diseases | |
| AU2003297397A2 (en) | Methods and compositions for the treatment of herpes virus infections using cyclooxygenase-2 selective inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents | |
| US20120277318A1 (en) | Non-steroidal anti-inflammatory drugs for cough | |
| RU2007132971A (ru) | Способы и материалы с транс-кломифеном для лечения мужского бесплодия | |
| CN109172550B (zh) | 一种复合麻醉药物 | |
| RU2020108631A (ru) | Новая вспомогательная терапия для применения в способе лечения рака простаты | |
| MX2022006404A (es) | Composicion farmaceutica para el tratamiento de la enfermedad vascular pulmonar y/o disfuncion cardiaca en pacientes paliados con fontan. | |
| FI3927340T3 (fi) | Tegopratsaania käsittävä lääkekoostumus gastroesofageaalisen refluksitaudin uusiutumisen estämiseksi | |
| JP2011514319A (ja) | 急性マラリアを治療するためのビス−チアゾリウム塩またはこれらの前駆体およびアルテミシニンまたはこれらの誘導体の組み合わせ | |
| US20060128719A1 (en) | Use of alpha-adrenergic blockers for the treatment of dysmenorrhea |